6 Results for "

COVID-19 pandemic

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "COVID-19 pandemic" in MCE Product Catalog:

76
76 Cited Publications
Cat. No.: HY-135853
CAS No.: 2492423-29-5
Purity:  99.85%
Synonyms: EIDD-2801; MK-4482
Research Areas:  

Infection

Molnupiravir (EIDD-2801) is an orally bioavailable proagent of the ribonucleoside analog EIDD-1931. Molnupiravir has broad spectrum antiviral activity against influenza virus and multiple coronaviruses, such as SARS-CoV-2, MERS-CoV, SARS-CoV. Molnupiravir has the potential for the research of COVID-19, and seasonal and pandemic influenza .
loading...
    loading...
Cat. No.: HY-135853S
Purity:  99.86%
Synonyms: EIDD-2801-d7; MK-4482-d7
Molnupiravir-d7 is the deuterium labeled Molnupiravir. Molnupiravir (EIDD-2801) is an orally bioavailable prodrug of the ribonucleoside analog EIDD-1931. Molnupiravir has broad spectrum antiviral activity against influenza virus and multiple coronaviruses, such as SARS-CoV-2, MERS-CoV, SARS-CoV. Molnupiravir has the potential for the research of COVID-19, and seasonal and pandemic influenza .
loading...
    loading...
Cat. No.: HY-155813
CAS No.: 3032440-80-2
Target:  

SARS-CoV

Research Areas:  

Infection

MPI60 is a potent SARS-CoV-2 M Pro inhibitor with high antiviral potency, low cellular cytotoxicity, and high in vitro metabolic stability. MPI60 can be used for SARS-CoV-2 research .
loading...
    loading...
Cat. No.: HY-135853R
CAS No.: 2492423-29-5
Synonyms: EIDD-2801 (Standard); MK-4482 (Standard)
Research Areas:  

Infection

Molnupiravir (Standard) is the analytical standard of Molnupiravir. This product is intended for research and analytical applications. Molnupiravir (EIDD-2801) is an orally bioavailable proagent of the ribonucleoside analog EIDD-1931. Molnupiravir has broad spectrum antiviral activity against influenza virus and multiple coronaviruses, such as SARS-CoV-2, MERS-CoV, SARS-CoV. Molnupiravir has the potential for the research of COVID-19, and seasonal and pandemic influenza .
loading...
    loading...
Cat. No.: HY-143418
CAS No.: 2761911-44-6
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-17 (Compound 16) is a potent SARS-CoV-2 nucleocapsid protein (NPro) inhibitor. SARS-CoV-2-IN-17 exhibits potent anti-viral activity with the EC50 of 2.18 μM. SARS-CoV-2-IN-17 binds to NPro with the low KD value of 7.82 μM, suggesting that SARS-CoV-2-IN-17 is a potent NPro ligand .
loading...
    loading...
Cat. No.: HY-143417
CAS No.: 2761911-40-2
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-16 (Compound 12) is a potent SARS-CoV-2 nucleocapsid protein (NPro) inhibitor. SARS-CoV-2-IN-16 exhibits potent anti-viral activity with the EC50 of 3.69 μM. SARS-CoV-2-IN-16 binds to NPro with the low KD value of 7.82 μM, suggesting that SARS-CoV-2-IN-16 is a potent NPro ligand .
loading...
    loading...